A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis
- 1 February 1994
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 106 (2) , 494-499
- https://doi.org/10.1016/0016-5085(94)90610-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of primary biliary cirrhosis with low-dose weekly methotrexateGastroenterology, 1991
- Natural history and prognostic variables in primary sclerosing cholangitisGastroenterology, 1991
- Medical Approaches to Primary Sclerosing CholangitisSeminars in Liver Disease, 1991
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990
- Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysisHepatology, 1989
- Primary Sclerosing Cholangitis and Low-Dose Oral Pulse Methotrexate TherapyAnnals of Internal Medicine, 1987
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Primary Sclerosing CholangitisArchives of internal medicine (1960), 1982
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.Gut, 1980